Ingelheim/Germany and St. Joseph/MO (22 September 2009) - Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica ...

Animal owners may think they know what happens during a veterinary visit — but a new global survey of 1,000+ veterinarians across 51 countries ...

DULUTH, Ga., Feb. 16, 2021 /PRNewswire/ -- Boehringer Ingelheim Animal Health USA Inc. today announced the creation of Pawru, Inc. as a separate Company within the Boehringer Ingelheim Animal Health ...

PARIS & INGELHEIM, Germany--(BUSINESS WIRE)--Sanofi and Boehringer Ingelheim announced today the signing of contracts to secure the strategic transaction initiated in December 2015 which consists of ...

Germany-based pharmaceutical company Boehringer Ingelheim will create 55 jobs at its Animal Health Global Innovation Center in Athens, GA. Pharmaceutical development and manufacturing company ...

Boehringer Ingelheim joins forces with Belgian biotech company GST which develops and produces state-of-the art stem cell products for horses and pets The acquisition follows two years of successful ...

When German pharma Boehringer Ingelheim completed a $12.5 billion asset swap with France’s Sanofi in 2016, BI traded its consumer health business for Sanofi’s veterinary unit and agreed to make the ...

MANHATTAN, Kan. (WIBW) - Boehringer Ingelheim and Kansas State University are joining forces to invest in the future of veterinary medicine. Kansas State University says Boehringer Ingelheim, a ...

Boehringer Ingelheim is investing nearly $50 million to expand its animal-health manufacturing site in Barceloneta, Puerto Rico. BARCELONETA, Puerto Rico, Nov. 13, 2019 /PRNewswire/ -- Boehringer ...

Boehringer Ingelheim Animal Health USA Inc. will create 225 jobs and invest more than $120 million in Georgia’s Gwinnett, Clarke, and Hall counties. The animal health company has located its North ...

PLEASANTON, Calif., Feb. 14, 2024 /PRNewswire/ -- Veeva Systems (VEEV) (NYSE: VEEV) today announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications as its ...

• Boehringer Ingelheim's research program on swine vaccines against PCV2/M.hyo revealed that the highest protection was observed for its vaccines when freshly mixed. • A ready-to-use (RTU) design does ...